Logo
x

Search

Subscribe Now

Astrazeneca

AstraZeneca Reports the CHMP’s Positive Opinion of Tagrisso (Osimertinib) for Treating Unresectable EGFR-Mutated Lung Cancer

AstraZeneca Reports the CHMP’s Positive Opinion of Tagrisso (Osimertinib) for Treating Unresectable EGFR-Mutated Lung Cancer

  • November 18, 2024
AstraZeneca Provides Update on P-III (KOMET) Study of Koselugo for Treating Neurofibromatosis Type 1

AstraZeneca Provides Update on P-III (KOMET) Study of Koselugo for Treating Neurofibromatosis Type 1

  • November 12, 2024
AstraZeneca Reports Data from the P-III (WAYPOINT) Study of Tezspire (Tezepelumab) for Chronic Rhinosinusitis with Nasal Polyps

AstraZeneca Reports Data from the P-III (WAYPOINT) Study of Tezspire (Tezepelumab) for Chronic Rhinosinusitis with Nasal Polyps

  • November 8, 2024
AstraZeneca’s Fasenra Receives EU Approval for Eosinophilic Granulomatosis with Polyangiitis

AstraZeneca’s Fasenra Receives EU Approval for Eosinophilic Granulomatosis with Polyangiitis

  • October 29, 2024
AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

  • October 28, 2024
AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the CHMP’s Positive Opinion to Treat Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the CHMP’s Positive Opinion to Treat Hereditary Transthyretin-Mediated Amylo...

  • October 21, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.